4 results

• FDA Cites Dr. Reddy Plant For Failing To Properly Test Solvents Linked To NDMA Contamination

  February 11, 2020

  Irvin Jackson

  An FDA inspection of a Dr. Reddy's plant in India found that it failed to adequately test out-of-specification drug results, raising particular concerns about the use of solvents, which are believed to have played a role in widespread generic valsartan recalls over the last two years.

• Dr. Reddy Halts Distribution of Generic Zantac Worldwide Over NDMA Contamination Concerns

  September 24, 2019

  Irvin Jackson

  Dr. Reddy's becomes the second drug manufacturer to halt distribution of generic Zantac, which may be contaminated with NDMA, a potentially cancer-causing agent.

• Generic Toprol XL Recalls Issued Following Years of Complaints

  June 25, 2014

  Irvin Jackson

  Two major generic Toprol XL recalls come after the FDA expresses concern over the quality of the generic forms of the hypertension drug.

• FDA Probes Generic Toprol XL Effectiveness Following Complaints

  May 8, 2014

  Irvin Jackson

  The FDA is calling for new studies into generic Toprol following thousands of reports that they are not as safe or effective as the brand name drug.